Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Biao Yang
Institutions:
Shenyang Medical College,
Wuhan Union Hospital,
Huazhong University of Science and Technology
Observed institutions:
Shenyang Medical College,
Wuhan Union Hospital,
Huazhong University of Science and Technology
ORCID:
0000-0003-4799-0905
Observed ORCID:
0000-0003-4799-0905
OpenAlex ID:
A5102676103
Development and evaluation of albumin binder-conjugated heterodimeric radiopharmaceuticals targeting integrin αvβ3 and CD13 for cancer therapy
2024
·
Biao Yang
, Changyu Shan
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
14
Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects
2024
·
Xiao Zhang
, Hanyi Fang
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
11
177Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy
2025
·
Biao Yang
, Changyu Shan
, et al.
·
Journal of Medicinal Chemistry
·
8
Preparation and evaluation of a novel albumin-binding heterodimer therapeutic radiopharmaceutical with remarkable tumor accumulation and retention
2025
·
Biao Yang
, Changyu Shan
, et al.
·
European Journal of Medicinal Chemistry
·
7
Clinical Translation of a Dual-Integrin αvβ3- and CD13-Targeting PET Tracer
2025
·
Xiao Zhang
, Biao Yang
, et al.
·
Clinical Nuclear Medicine
·
6
Design, Synthesis, and Evaluation of OncoFAP Derivatives with the Albumin Binder as Novel Antitumor Radiopharmaceuticals
2025
·
Biao Yang
, Yinfei Chen
, et al.
·
Chemical & Biomedical Imaging
·
3
PDF
Mg Alloys Reduce Gastric Cancer and Mediate Therapeutic Management of Antibacterial Function
2025
·
Yonghong Wu
, Xiaoyun Lu
, et al.
·
Journal of Functional Biomaterials
Show more works
View as search
Works count:
7
Citation count:
49
H-index:
5
I10-index:
2
Year
Topic
Type
